In this article, "9-HHC" refers to the informational topic focused on legal CBD derived from hemp in France —not the psychoactive molecule HHC, classified as a narcotic since 2023. If you are looking to buy compliant CBD or understand the risks associated with mislabeled products, you've come to the right place. The most important step before any purchase: request and read the product's Certificate of Analysis (COA) .
What you should check immediately on a COA:
- Measured Δ9-THC level (must be less than 0.30%)
- Advertised CBD level vs. actual level
- Presence or absence of other cannabinoids (HHC, H4-CBD, THCP, etc.)
- Name and accreditation of the third-party laboratory
- Batch number corresponding to your product
Table of Contents
- What does "9-HHC" really mean in this guide?
- What is the legal framework for CBD in France today?
- Legal CBD vs. HHC products: what are the concrete health risks?
- Why CBD product labeling is often misleading
- What drug interactions should you be aware of before using CBD?
- How to buy legal and safe CBD in France: the checklist
- What should you do if you experience side effects or have doubts about a product?
- Key points
- What the experience of the French market really reveals
- Legal and traceable CBD, without compromising on quality
- Official sources for further information
What does "9-HHC" really mean in this guide?
The term "9-HHC" circulates on the French market with very different meanings depending on the seller. In this guide, it refers exclusively to the world of legal CBD derived from hemp (Cannabis sativa L.) and to issues of compliance, safety, and responsible purchasing in France.
This guide does not address the HHC (hexahydrocannabinol) molecule itself. TheANSM (French National Agency for Medicines and Health Products Safety) classified HHC and two of its derivatives as narcotics as of June 13, 2023, prohibiting their production, sale, and use. Therefore, treating this molecule as a wellness product would be legally and health-related inaccurate.
The reference entities involved here are: theANSM (National Agency for the Safety of Medicines and Health Products), the Council of State, theAnses (National Agency for Health Security) and Lord Of Cbd, a player in the French legal CBD market.
What is the legal framework for CBD in France today?
CBD derived from hemp is legal in France under specific conditions. The key threshold: a Δ9-THC level of less than 0.30% in the plant and in the finished product, in accordance with thedecree of December 30, 2021 relating to authorized varieties of Cannabis sativa L.
The key decision remains that of the Council of State, which overturned the decree prohibiting the sale of hemp flowers and leaves containing less than 0.30% THC, on the grounds that this prohibition was disproportionate to the risks actually demonstrated. In other words, French regulations are based on the actual dose ingested and the method of consumption, not on a binary prohibition.
Key points to remember about the legal framework:
- The authorized varieties must be listed on the European list of certified seeds
- The official method for measuring THC is gas chromatography (GC), with a tolerance of 0.03% in absolute value
- CBD-based food products (oils, capsules, candies) fall under the European regulation on novel foods and require specific authorization, as Ameli
- Since June 2024, the ANSM has extended the bans to new cannabinoids: H4-CBD, H2-CBD, HHCPO, THCP and THCA are now classified as narcotics
Key takeaway: a product labeled "legal cannabinoid" or "hemp" guarantees nothing. Only a Certificate of Analysis (COA) from an accredited laboratory confirms actual compliance.
Legal CBD vs. HHC products: what are the concrete health risks?
The confusion between CBD and HHC is not insignificant. The ANSM (French National Agency for Medicines and Health Products Safety) has classified HHC as a narcotic due to a risk of abuse and addiction comparable to cannabis. Reported effects of HHC include tremors, acute anxiety, tachycardia, and dissociative states—symptoms similar to those of THC intoxication.
Legal CBD is not without its side effects. Mislabeled or contaminated, it can cause excessive drowsiness, digestive problems, or, in severe cases, serious drug interactions. The line between the two is not always clear: reports from addiction monitoring services show that some consumers have ingested HHC believing they were buying CBD, particularly through e-liquids, oils, or gummies.
The fundamental difference lies in analytical traceability: a compliant CBD product has a Certificate of Analysis (COA) that lists all detected cannabinoids. A product without a COA or with an incomplete COA can contain anything.
Why CBD product labeling is often misleading
TheFrench Agency for Food, Environmental and Occupational Health & Safety (ANSES) is warning of an increase in poisonings linked to CBD products containing other cannabinoids not declared on the label. According to the ANSM (French National Agency for Medicines and Health Products Safety), the number of these reports has increased significantly since 2024.
| Common anomaly | Consequence for the buyer |
|---|---|
| THC level greater than 0.30% | Positive test result, legal risk |
| Undeclared cannabinoids (HHC, THCP) | Unexpected psychoactive effects, intoxication |
| CBD level lower than advertised | Ineffective product, commercial scam |
| Uncontrolled residual solvents | Long-term toxicological risks |
| No batch number | Traceability is impossible in case of a problem |
Official controls use the GC method with a tolerance of 0.03% in absolute value. A reputable Certificate of Analysis (COA) must specify this method, the accredited laboratory, and the date of analysis corresponding to the lot in question.
Pro tip: Check that the batch number on the packaging exactly matches the one indicated on the COA. A discrepancy is enough to invalidate the document.
What drug interactions should you be aware of before using CBD?
The ANSM (French National Agency for Medicines and Health Products Safety) is clear: mixing CBD with certain medications can reduce their effectiveness or amplify their side effects. The most frequently reported symptoms are nausea, diarrhea, dizziness, drowsiness, fatigue, and headaches. In more serious cases, seizures or suicidal thoughts have been reported.
People particularly at risk:
- Patients taking antiepileptic drugs (CBD may alter plasma concentrations)
- People taking immunosuppressants or anticoagulants
- People suffering from liver failure (CBD is metabolized by the liver)
- Pregnant or breastfeeding women
As a general precaution: if you are taking any other medication, discuss your CBD use with your doctor before starting. Do not drive if you experience drowsiness or dizziness after taking CBD.
Stop taking the product and consult a healthcare professional if you experience any unusual symptoms within hours of consumption, especially palpitations, confusion, or respiratory distress.
How to buy legal and safe CBD in France: the checklist
- Ask for the Certificate of Authenticity (COA) before buying. Any reputable seller will provide it upon request or publish it online, along with the batch number.
- Check the measured Δ9-THC level : it must be less than 0.30%, confirmed by GC method.
- Check the full list of cannabinoids : the COA must mention CBD, THC, CBG, CBN and the absence of HHC, THCP or other molecules classified as narcotics.
- Identify the laboratory : it must be accredited (ISO 17025 standard or equivalent) and independent of the seller.
- Check the origin of the plant : certified variety, preferably hemp from the European Union, extraction method indicated (supercritical CO₂, ethanol, etc.).
- Beware of warning signs : absence of COA, unauthorized claims of medical benefits, abnormally low price, label without batch number or manufacturer's contact details.
- Keep your proof of purchase and the complete packaging until you have finished using the product.
| COA Field | What he needs to indicate |
|---|---|
| Δ9-THC | Less than 0.30% (GC method specified, tolerance of 0.03% in absolute value) |
| CBD | Measured rate corresponding to the label |
| Other cannabinoids | Comprehensive list with values |
| Residual solvents | Absence or values below regulatory thresholds |
| Batch number | Identical to that of the packaging |
| Laboratory | Name, accreditation, date of analysis |
Pro tip: For CBD flowers, ask directly about the variety being grown and whether it is registered in the official European seed catalogue — this is the legal basis of the entire chain.
What should you do if you experience side effects or have doubts about a product?
- Report the adverse effect to the ANSM — via the national reporting portal (signalement.social-sante.gouv.fr) or to a Centre for Evaluation and Information on Drug Dependence (CEIP-A).
This guide provides general information, not medical or legal advice. Consult a healthcare professional or lawyer for your specific situation.
Key points
Legal CBD in France is regulated by a THC threshold of 0.30% and an analytical traceability requirement that only a COA from an accredited laboratory can confirm.
| Point | Details |
|---|---|
| Legal THC threshold | The Δ9-THC must be less than 0.30% in the finished product, verified by GC method. |
| HHC is classified as a narcotic | The ANSM has banned HHC and its derivatives since June 2023; other cannabinoids followed in June 2024. |
| Risk of misleading labeling | Cases of poisoning have been caused by undeclared cannabinoids in products sold as CBD. |
| Drug interactions | The ANSM recommends informing your doctor before using CBD if you are currently undergoing treatment. |
| Lord Of CBD | Offers CBD products derived from organic hemp with accessible COAs and THC levels below 0.30%. |
What the experience of the French market really reveals
The real problem with the CBD market in France isn't the molecule itself. It's the lack of analytical knowledge among some buyers and, let's be honest, among some sellers. People buy oil or flower based on the label, without ever asking for the Certificate of Analysis (COA). Yet, it's precisely this document that makes the difference between a compliant product and one that could lead to a positive test or even poisoning.
The Council of State's decision on proportionality is often misunderstood: it doesn't mean anything goes, but that regulations must be adapted to the reality of the measured risks. This principle should guide every buyer: assess the actual risk of the product you have in your hand, not that of the abstract category "CBD".
The other blind spot: drug interactions. These are systematically underestimated because CBD is perceived as natural and therefore harmless. The ANSM (French National Agency for Medicines and Health Products Safety) had to issue a specific warning on this point. A natural product can perfectly well inhibit liver enzymes and alter the concentration of critical medications in the blood.
Legal and traceable CBD, without compromising on quality
You now have the criteria to distinguish a compliant product from a questionable one. Lord Of Cbd applies these exact standards: selected organic hemp, THC content below 0.30% in each batch, accessible Certificates of Analysis (COA) from third-party laboratories, and traceable batch numbers.
The selection includes flowers, resins, oils, e-liquids, and capsules, all sourced from rigorously vetted producers. For shoppers who want to try a product without committing to a single purchase, the CBD Box allows you to discover several controlled formats in one order. If you're looking for a wellness product with complete traceability, browse the catalog directly on lordofcbd.fr and contact customer service with any questions before finalizing your order.
Official sources for further information
| Source | What it contains |
|---|---|
| ANSM — Classification of HHC and derivatives (2023) | Decision regarding classification as a narcotic, effective date, molecules concerned |
| ANSM — New cannabinoids to be classified (2024) | H4-CBD, H2-CBD, HHCPO, THCP, THCA banned since June 2024 |
| ANSM — CBD and medicines | Interactions, symptoms to monitor, clinical recommendations |
| Anses — Intoxications related to CBD products | Alerts on undeclared cannabinoids, vigilance data |
| Council of State — Decision on CBD flowers | Cancellation of the order, principle of proportionality |
| Official Journal — Decree 2021 and CPG Method | Threshold 0.30% THC, official analytical method, tolerance 0.03% |
| Ameli — Non-medical CBD | New food regulations, precautions for general public use |
To verify a product's compliance, start with the Certificate of Analysis (COA): compare the batch number, analytical method, and measured values with the official thresholds listed in these documents. If you have any doubts about a purchased product, the ANSM's reporting portal (signalement.social-sante.gouv.fr) is the official point of contact.